This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universitetet I Oslo. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Hesso Farhan: Innovator in Cancer Treatment
Introduction
Hesso Farhan is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of cancer treatment, particularly through his innovative research on ALK inhibitors. His work focuses on addressing ALK-negative cancers and plasma cell-mediated diseases, which are critical areas in oncology.
Latest Patents
Hesso Farhan holds 1 patent for his invention titled "ALK inhibitors for treatment of ALK-negative cancer and plasma cell-mediated diseases." This patent presents a method for treating ALK-negative/LTK-positive cancer by administering a pharmaceutically-effective dose of a linear inhibitor of ALK. The invention is particularly useful in treating multiple myeloma, including cases that are resistant to proteasome inhibitors.
Career Highlights
Farhan is affiliated with the University of Oslo, where he conducts his research and development in cancer therapies. His academic background and ongoing research contribute to the advancement of medical science, particularly in the treatment of challenging cancer types.
Collaborations
Hesso Farhan collaborates with esteemed colleagues such as Ludvig Munthe and Kjetil Tasken. Their combined expertise enhances the research efforts at the University of Oslo, fostering innovation in cancer treatment.
Conclusion
Hesso Farhan's work in developing ALK inhibitors represents a significant advancement in the fight against cancer. His contributions are vital for improving treatment options for patients with ALK-negative cancers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile